|
|
|
| Meet the Next Evolution of ddPCR Solutions | Introducing Bio-Rad's most advanced Droplet Digital™ PCR (ddPCR™) systems yet — the QX Continuum™ and QX700™ systems series, which set new standards in sensitivity, workflow simplicity, ease of multiplexing, and performance through absolute quantification. Learn More |
|
|
|
|
By BioPhorum | In setting up a new manufacturing facility, a robust process for environmental monitoring must be established and cleanrooms in the classified areas must be properly qualified. Here are critical considerations to keep in mind. | |
|
|
| Navigating Cell Therapy Process Development | e-book | Cytiva | Equip yourself with the knowledge necessary to make well-informed decisions by exploring the main challenges and considerations inherent in cell therapy process development. |
|
|
| Advancements In Gene Therapy Development | Q&A | QIAGEN | Gene therapy is transforming treatment for genetic disorders. With over 30 FDA-approved therapies, gain expert insight into how digital PCR enhances AAV vector precision, safety, and regulatory compliance in development. |
|
|
|
|
| Overcoming Challenges In CGT Development | Webinar | CPC | Explore connector solutions for sterility, chemical compatibility, and ultra-low temperature challenges when setting up a therapeutic process for long-term success. |
|
|
| Enhancing Process Development With Viral Clearance | Webinar | Bio-Rad Laboratories, Inc. | Streamline mAb purification with confidence. Learn practical considerations for developing processes with advanced mixed-mode chromatography, ensuring superior impurity and viral clearance from the start. |
|
|
| Challenges In Viral Vector Production & Innovative Solutions | Article | By Brian Moloney, Single Use Support | Single-use technology is playing a large role in increasing flexibility and reducing contamination risks for the biopharmaceutical industry. Take a deeper look into all of the advantages and challenges. |
|
|
| Development And Optimization Of LNP Formulations | Application Note | KNAUER | The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs. |
|
|
|
|
| Webinar: Solving Fragmentation: Expert Insights on Future-Proofing the Advanced Therapy Supply Chain | This Cryoport webinar explores how integrated, purpose-built supply chain platforms can overcome the risks and delays of fragmented logistics in cell and gene therapy. Industry leaders share real-world strategies for standardizing collection, cryopreservation, and storage, aligning logistics with manufacturing, and scaling operations globally to improve reliability, accelerate commercialization, and enhance patient outcomes. Click here to learn more. |
|
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|